Meanwhile, since our previous study also showed that IRF1 recruited NK cells and CD8+T cells through CXCL10/CXCR3 axis [14], we investigated whether IRF1-MICA signaling recruited anti-tumor immune cells via the CXCR3 receptor. Here, CXCL10 is linked to neoplasm.